ABSTRACT
In July, a group of scientists presented results of experiment in which they successfully engineered hybrid kidneys for transplantations. These organs – taken from pigs and coated with human placental cells that prevent the organ’s rejection – can solve both the shortage and the rejection problem. In the epilogue, I reflect on this experiment as well as on the development of bioprinted organs for transplants and wonder what would the political economy of organ transplantations will look like when shortage ends and what are the new ethical challenges of this future.
